Grow consult volume and downstream diagnostics by activating men who aren’t entering care.
Urology Insights identifies and converts undiagnosed, untreated higher‑risk men who are not responding to awareness campaigns, PCP nudges, or standard referral pathways.
Why this matters
A meaningful share of clinically significant disease sits in a population that doesn’t behave like “patients.” The primary barrier isn’t access — it’s fear, denial, mistrust, and avoidance. That creates a gap between community risk and arriving volume.
What we do
Why this is different from “marketing”
Most marketing increases awareness. This system increases conversion among the people who normally do nothing. It’s designed around validated risk frameworks (PCPT/ERSPC‑derived) and built to move high‑intent men into care—without requiring your team to manage campaigns, creatives, or tech.
What you receive
- Consult requests from a population you’re not currently reaching
- Structured patient summary (risk pathway + symptom/risk flags)
- Clear next‑step recommendation (PSA, mpMRI, consult, etc.)
Who this is for
- Seeking measurable growth in consults and downstream procedures
- A high‑volume service line (robotics optional)
- Focused on earlier capture of clinically significant disease
- Not accepting new patients
- Unable to accommodate increased consults/diagnostics
- No pathway to route patients through PSA → mpMRI/biopsy where appropriate
Request a Local Market Brief
Submit the form and we’ll send a brief tailored to your catchment: estimated undiagnosed/untreated higher‑risk pool, expected consult & diagnostic volumes (conservative assumptions), recommended messaging angles, and a 90‑day implementation outline sized to your goals.